Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 383,745 | 543,064 | 696,148 | 161,412 | 108,497 |
| Marketable Securities | 1,641,934 | 1,746,235 | 1,156,807 | 483,531 | 468,557 |
| Receivables | N/A | N/A | 1,254 | 4,673 | 5,929 |
| TOTAL | $2,075,037 | $2,327,632 | $1,879,281 | $660,185 | $589,773 |
| Non-Current Assets | |||||
| PPE Net | 33,194 | 24,289 | 22,865 | 18,659 | 11,544 |
| Investments And Advances | 24,148 | 12,128 | 0 | 0 | 0 |
| Intangibles | 70,408 | 71,278 | 72,347 | 73,415 | 74,484 |
| Other Non-Current Assets | 151,721 | 122,974 | 87,212 | 59,671 | 62,187 |
| TOTAL | $279,471 | $230,669 | $182,424 | $151,745 | $148,215 |
| Total Assets | $2,354,508 | $2,558,301 | $2,061,705 | $811,930 | $737,988 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 64,616 | 54,427 | 61,788 | 21,306 | 14,057 |
| Accrued Expenses | 209,340 | 96,615 | 74,694 | 29,446 | 27,721 |
| TOTAL | $290,424 | $163,914 | $143,851 | $61,984 | $60,350 |
| Non-Current Liabilities | |||||
| Long Term Debt | 268,446 | N/A | N/A | N/A | N/A |
| Deferred Revenues | N/A | N/A | N/A | 4,459 | 12,358 |
| Other Non-Current Liabilities | 161,988 | 126,830 | 88,545 | 57,733 | 61,053 |
| TOTAL | $432,787 | $129,183 | $91,660 | $64,758 | $75,070 |
| Total Liabilities | $723,211 | $293,097 | $235,511 | $126,742 | $135,420 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 198,173 | 185,913 | 164,690 | 90,492 | 74,189 |
| Common Shares | 19 | 18 | 16 | 9 | 8 |
| Retained earnings | -2,869,102 | -1,737,801 | -1,137,708 | -701,341 | -452,636 |
| Other shareholders' equity | 3,237 | 1,321 | 544 | -1,780 | -376 |
| TOTAL | $1,631,297 | $2,265,204 | $1,826,194 | $685,188 | $602,568 |
| Total Liabilities And Equity | $2,354,508 | $2,558,301 | $2,061,705 | $811,930 | $737,988 |